CAC Software vs ZEUS System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by 4DMedical (Imbio CAC Software)
VS
by iRhythm Technologies, Inc.

AI Verdict

Tool A (CAC Software) specializes in quantifying coronary artery calcification from CT scans to assess cardiovascular disease risk. In contrast, Tool B (ZEUS System) focuses on detecting and characterizing cardiac arrhythmias through continuous ECG monitoring from wearable biosensors. While both leverage AI in cardiology, they address distinct clinical problems using different data types and methodologies, making them complementary rather than direct competitors.

Choose CAC Software if…

Choose Imbio's CAC Software if you need to assess a patient's risk for coronary artery disease by quantifying calcification in their coronary arteries. This tool is ideal for radiologists and cardiologists seeking automated, deep-learning based analysis of non-contrast chest CT scans to generate an Agatston score and provide 3D visualizations for comprehensive risk stratification.

View CAC Software →

Choose ZEUS System if…

Choose iRhythm Technologies' ZEUS System if you require long-term continuous cardiac monitoring to detect and characterize arrhythmias, such as Atrial Fibrillation. This AI-powered solution is best suited for physicians in cardiology, family medicine, or internal medicine who need to analyze ECG data from wearable biosensors for up to 14 days to identify both symptomatic and asymptomatic cardiac events.

View ZEUS System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC Software ZEUS System
Pricing Unknown Not disclosed
Deployment Cloud-based (SaaS), integrates with PACS Cloud-based (AWS EC2 platform), no on-premise hardware.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools are designed for seamless integration into existing clinical workflows. Tool A integrates into standard DICOM viewing workflows for radiologists, providing 3D visualizations and annotated images. Tool B offers cloud-based analytics, preliminary report generation, and HL7-based EHR integration for physicians managing continuous ECG monitoring. Given their distinct target users and integration points, neither can be definitively declared superior in overall usability without user-specific feedback.

Clinical Value

Tie

Both tools offer significant and distinct clinical value in their respective domains within cardiology. Tool A provides automated, quantitative assessment of coronary artery calcification for CAD risk assessment. Tool B enables AI-powered, long-term continuous ECG monitoring for early arrhythmia detection and characterization. Both are FDA cleared, validating their clinical utility and safety.

Pricing & Value

Tie

Neither Tool A nor Tool B discloses specific pricing information in the provided structured facts or readily available online. Both require direct contact for pricing details. Without transparent pricing, it is impossible to conduct a meaningful comparison of their cost-effectiveness or overall value proposition.

Enterprise Readiness

CAC Software

Tool A offers greater deployment flexibility, supporting Cloud, On-premise, and Partner platforms. This range of options can be crucial for enterprises with varying IT infrastructure preferences and data governance requirements. While Tool B is also HIPAA compliant, has a BAA, and integrates with EHRs, its cloud-only deployment may be a limitation for some organizations.

Innovation

ZEUS System

Tool B demonstrates a more disruptive innovation by combining AI-powered analysis with wearable biosensors for long-term continuous cardiac monitoring. This approach extends diagnostic capabilities beyond traditional clinical settings, enabling early detection and management of arrhythmias. While Tool A's deep-learning based image analysis is innovative, Tool B's integration with wearables for continuous patient monitoring represents a more transformative step in patient care delivery.

Support & Docs

ZEUS System

Tool B provides more readily accessible and comprehensive support resources, including 24/7 patient support via phone and email, and downloadable Instructions for Use and Clinical Reference Manuals in multiple languages. Tool A offers online case submission, phone, and email support during business hours, with documentation available upon request. Tool B's transparent and multi-faceted approach to support and documentation gives it an edge.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC Software ZEUS System
Name CAC Software ZEUS System
Company Imbio iRhythm Technologies
Description Automated image post-processing algorithms designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT). AI-powered software that analyzes ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation.
Primary Function Coronary Artery Calcification (CAC) quantification Arrhythmia detection and characterization from ECG data
Data Input Non-contrast chest computed tomography (CT) scans ECG data from wearable biosensors
Key Output/Analysis Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations, annotated images Detection and characterization of Atrial Fibrillation (AFib), preliminary report generation

Videos

Demos, reviews, and walkthroughs featuring CAC Software and ZEUS System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio's CAC Software is designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries for risk assessment of coronary artery disease. The ZEUS System by iRhythm Technologies analyzes ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation.
Imbio's CAC Software analyzes non-contrast chest computed tomography (CT) images. The ZEUS System analyzes ECG data from wearable biosensors, specifically integrating with Zio Watch and Zio monitors.
Imbio's CAC Software outputs the Agatston score, arterial age, calcified lesion mass, and volume, along with 3D visualizations and annotated images. The ZEUS System provides AI-powered arrhythmia detection and characterization, including Atrial Fibrillation, and generates preliminary reports for physicians.
Imbio's CAC Software is primarily intended for use by cardiologists and radiologists. The ZEUS System serves cardiologists, family medicine practitioners, and internal medicine specialists.
Imbio's CAC Software integrates into existing DICOM viewing workflows, automatically sending analysis outputs such as 3D DICOM series and quantitative reports to PACS. The ZEUS System supports HL7-based EHR integration and provides preliminary reports to clinicians via a secure website for review.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.